Mitomycin C and Cisplatin Enhanced the Antitumor Activity of p53-Expressing Adenovirus in Cervical Cancer Cells

REFERENCES

• Suresh K. G., Lipman R., Cummings J., Tomasz M. Mitomycin C-DNA Adducts Generated by DT-Diaphorase. RevisedMechanism of the Enzymatic Reductive Activation of Mitomycin C. Biochemistry 1997; 36: 14128–14136
   PubMed Web of Science ®Google Scholar
• Chu G. Cellular Responses to Cisplatin. The Roles of DNA-Binding Proteinsand DNA Repair. J. Biol. Chem. 1994; 269: 787–790
   PubMed Web of Science ®Google Scholar
• Fritsche M., Haessler C., Brandner G. Induction of Nuclear Accumulation of the Tumor-Suppressor Proteinp53 by DNA-Damaging Agents. Oncogene 1993; 8: 307–318
   PubMed Web of Science ®Google Scholar
• Ko L. J., Prives C. p53: Puzzle and Paradigm. Genes Dev. 1996; 10: 1054–1072
   PubMed Web of Science ®Google Scholar
• Wang X. W., Harris C. C. TP53 Tumour Suppressor Gene: Clues to Molecular Carcinogenesisand Cancer Therapy. Cancer Surv. 1996; 28: 169–196
   PubMedGoogle Scholar
• Yonish R. E., Deguin V., Zaitchouk T., Breugnot C., Mishal Z., Jenkin J. R., May E. Transcriptional Activation Plays a Role in the Induction ofApoptosis by Transiently Transfected Wild-Type p53. Oncogene 1995; 11: 2197–2205
   PubMed Web of Science ®Google Scholar
• Haupt Y., Rowan S., Shaulian E., Kazaz A., Vousden K., Oren M. Induction of Apoptosis in HeLa Cells by Trans-Activation-Deficientp53. Genes Dev. 1995; 9: 2170–2183
   PubMed Web of Science ®Google Scholar
• Chen X., Ko L. J., Jayaraman L., Prives C. p53 Levels, Functional Domains, and DNA Damage Determine theExtent of the Apoptotic Response of Tumor Cells. Genes Dev. 1996; 10: 2438–2451
   PubMed Web of Science ®Google Scholar
• Levine A. J. p53, the Cellular Gatekeeper for Growth and Division. Cell 1997; 88: 323–331
   PubMed Web of Science ®Google Scholar
• Nelson W. G., Kastan M. B. DNA Strand Breaks: The DNA Template Alterations That Triggerp53-Dependent DNA Damage Response Pathways. Mol. Cell Biol. 1994; 14: 1815–1823
   PubMed Web of Science ®Google Scholar
• Yamaizumi M., Sugano T. UV-Induced Nuclear Accumulation of p53 Is Evoked Through DNADamage of Actively Transcribed Genes Independent of the Cell Cycle. Oncogene 1994; 9: 2775–2784
   PubMed Web of Science ®Google Scholar
• Butz K., Shahabeddin L., Geisen C., Spitkovsky A., Ullmann A., Hoppe-Seyler F. Functional p53 Protein in Human Papillomavirus-Positive CancerCells. Oncogene 1995; 10: 927–936
   PubMed Web of Science ®Google Scholar
• Oren M., Prives C. p53: Upstream, Downstream and Off Stream. Biochim. Biophys. Acta 1996; 1288: R13–R19
   PubMed Web of Science ®Google Scholar
• Strasser A., Harris A. W., Jacks T., Cory S. DNA Damage Can Induce Apoptosis in Proliferating Lymphoid Cellsvia p53-Independent Mechanisms Inhibitable by Bcl-2. Cell 1994; 79: 329–339
   PubMed Web of Science ®Google Scholar
• Dou Q. P., An B., Will P. L. et al. Induction of a Retinoblastoma Phosphatase Activity byAnticancer Drugs Accompanies p53-Independent G1 Arrest and Apoptosis. Proc. Natl. Acad. Sci. U.S.A. 1995; 92: 9019–9023
   PubMed Web of Science ®Google Scholar
• Chinery R., Brockman J. A., Peeler M. O., Shyr Y., Beauchamp R. D., Coffey R. J. Antioxidants Enhance the Cytotoxicity of Chemotherapeutic Agentsin Colorectal Cancer: A p53-Independent Induction of p21WAF1/CIP1 via C/EBPbeta. Nat. Med. 1997; 3: 1233–1241
   PubMed Web of Science ®Google Scholar
• Zamble D. B., Jacks T., Lippard S. J., et al. p53-Dependent and -Independent Responses to Cisplatin in MouseTesticular Teratocarcinoma Cells. Proc. Natl. Acad. Sci. U.S.A. 1998; 95: 6163–6168
   PubMed Web of Science ®Google Scholar
• Macleod K. F., Sherry N., Hannon G., Beach D., Tokins T., Kinzler K., Vogelstein B. p53-Dependent and Independent Expression of p21 During CellGrowth, Differentiation, and DNA Damage. Genes Dev. 1995; 9: 935–944
   PubMed Web of Science ®Google Scholar
• Nguyen D. M., Spitz F. R., Yen N., Cristiano R. J., Roth J. A. Gene Therapy for Lung Cancer: Enhancement of Tumor Suppressionby a Combination of Sequential Systemic Cisplatin and Adenovirus-Mediatedp53 Gene Transfer. J. Thorac. Cardiovasc. Surg. 1996; 112: 1372–1376
   PubMed Web of Science ®Google Scholar
• Ogawa N., Fujiwara T., Kagawa S., Nishizaki M., Morimoto Y., Tanida T., Hizuta A., Yasuda T., Roth J. A. Novel Combination Therapy for Human Colon Cancer with Adenovirus-MediatedWild-Type p53 Gene Transfer and DNA-Damaging Chemotherapeutic Agent. Int. J. Cancer 1997; 73: 367–370
   PubMed Web of Science ®Google Scholar
• Nielsen L. L., Lipari P., Dell J., Gurani M., Hajian G. Adenovirus-Mediated p53 Gene Therapy and Paclitaxel Have SynergisticEfficacy in Models of Human Head and Neck, Ovarian, Prostate, and Breast Cancer. Clin. Cancer Res 1998; 4: 835–846
   PubMed Web of Science ®Google Scholar
• Blagosklonny M. V., El-Deiry W. S. Acute Overexpression of wt p53 Facilitates Anticancer Drug-InducedDeath of Cancer and Normal Cells. Int. J. Cancer 1998; 75: 933–940
   PubMed Web of Science ®Google Scholar
• Hansen M. B., Nielsen S. E., Berg K. Re-Examination and Further Development of a Precise and RapidDye Method for Measuring Cell Growth/Cell Kill. J. Immunol. Methods 1989; 119: 203–210
   PubMed Web of Science ®Google Scholar
• Graham F. L., Prevec L. Methods for Construction of Adenovirus Vectors. Mol. Biotechnol. 1995; 3: 207–220
   PubMed Web of Science ®Google Scholar
• Gorczyca W., Gong J., Darzynkiewicz Z. Detection of DNA Strand Breaks in Individual Apoptotic Cellsby the in Situ Terminal Deoxynucleotidyl Transferase and Nick TranslationAssays. Cancer Res. 1993; 53: 1945–1951
   PubMed Web of Science ®Google Scholar
• Hoppe-Seyler F., Butz K., Rittmuller C., von Knebel M. Doeberitz. A Rapid Microscale Procedure for the Simultaneous Preparationof Cytoplasmic RNA, Nuclear DNA Binding Proteins and Enzymatically ActiveLucif- erase Extracts. Nucleic Acids Res. 1991; 19: 5080
   PubMed Web of Science ®Google Scholar
• Ngan H. Y.S., Stanley M., Liu S. S., Ma H. K. HPV and p53 in Cervical Cancer. Genitourin. Med 1994; 70: 167–170
   PubMedGoogle Scholar
• Scheffner M. K., Werness B. A., Huibregtse J. M., Levine A., Howley P. M. The E6 Oncoprotein Encoded by Human Papillomavirus Types 16and 18 Promotes the Degradation of p53. Cell 1990; 63: 1129–1136
   PubMed Web of Science ®Google Scholar
• Hamada K., Alemany R., Zhang W. W., Hittelman W. N., Lotan R., Roth J. A., Mitchell M. F. Adenovirus-Mediated Transfer of a Wild-Type p53 Gene and Inductionof Apoptosis in Cervical Cancer. Cancer Res. 1996; 56: 3047–3054
   PubMed Web of Science ®Google Scholar
• Gurnani M., Lipari P., Dell J., Shi B., Nielsen L. L. Adenovirus-Mediated p53 Gene Therapy Has Greater Efficacy WhenCombined with Chemotherapy Against Human Head and Neck, Ovarian, Prostateand Breast Cancer. Cancer Chemother. Pharmacol. 1999; 44: 143–151
   PubMedGoogle Scholar
• Kilic G., Cardillo M., Ozemirli M., Arun B. Human Papillomavirus 18 Oncoproteins E6 and E7 Enhance Irradiation-and Chemotherapeutic Agent-Induced Apoptosis in p53 and Rb Mutated CervicalCancer Cell Lines. Eur. J. Gynaecol. Oncol. 1999; 20: 167–171
   PubMed Web of Science ®Google Scholar
• Burger H., Nooter K., Boersma A. W., Kortland C. J., Stoter G. Lack of Correlation Between Cisplatin-Induced Apoptosis, p 53Status and Expression of Bcl-2 Family Proteins in Testicular Germ Cell TumourCell Lines. Int. J. Cancer 1997; 73: 592–599
   PubMed Web of Science ®Google Scholar
• Gujuluva C. N., Baek J. H., Shin K. H., Cherrick H. M., Park N. H. Effect of UV-Irradiation on Cell Cycle, Viability and the Expressionof p53, gadd153 and gadd45 Genes in Normal and HPV-Immortalized Human OralKeratinocytes. Oncogene 1994; 9: 1819–1827
   PubMed Web of Science ®Google Scholar
• Okorokov A. L., Ponchel F., Milner J. Induced N- and C-Terminal Cleavage of p53: A Core Fragment ofp53, Generated by Interaction with Damaged DNA, Promotes Cleavage of the N-Terminusof Full-Length, p53, Whereas ssDNA Induces C-Terminal Cleavage of p53. EMBO J. 1997; 16: 6008–6017
   PubMed Web of Science ®Google Scholar